The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

PURPOSE: Immune checkpoint inhibition is a therapeutic option in many cancer entities. In head and neck squamous cell carcinoma (HNSCC) targeting of the PD-1/PD-L1 (B7-H1) axis is approved in recurrent/metastatic disease and is being explored in the curative setting. Here, we evaluated two related m...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgmann, Mara, Oetting, Agnes, Meyer, Felix, Möckelmann, Nikolaus, Droste, Conrad, von Bargen, Clara Marie, Möller-Koop, Christina, Witt, Melanie, Borgmann, Kerstin, Rothkamm, Kai, Betz, Christian, Münscher, Adrian, Clauditz, Till Sebastian, Rieckmann, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314856/
https://www.ncbi.nlm.nih.gov/pubmed/35941227
http://dx.doi.org/10.1007/s00432-022-04244-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314856/
https://www.ncbi.nlm.nih.gov/pubmed/35941227
http://dx.doi.org/10.1007/s00432-022-04244-2

Ejemplares similares